Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced the dosing of the first participant in the Phase II clinical trial, PROSPER. The study ...

CHICAGO -- Civil rights activist Rev. Jesse Jackson was hospitalized on Wednesday in Chicago, according to the Rainbow PUSH Coalition. Sources told our sister station WLS that Jackson was being ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It is a rare disease that may appear similar to some other neurodegenerative ...